Get the Stockscreener App
0.75
1.37%
0.0101
After Hours:
.75
Moolec Science Sa stock is traded at $0.75, with a volume of 9,308.
It is up +1.37% in the last 24 hours and up +1.06% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
See More
Previous Close:
$0.7399
Open:
$0.6456
24h Volume:
9,308
Relative Volume:
0.47
Market Cap:
$30.00M
Revenue:
$5.63M
Net Income/Loss:
$-7.31M
P/E Ratio:
-3.75
EPS:
-0.2
Net Cash Flow:
$-9.49M
1W Performance:
+15.38%
1M Performance:
+1.06%
6M Performance:
-20.38%
1Y Performance:
-57.87%
1-Day Range:
$0.6456
$0.80
1-Week Range:
$0.59
$0.85
52-Week Range:
$0.53
$3.25
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
0.75 | 30.00M | 5.63M | -7.31M | -9.49M | -0.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.31 | 124.11B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
684.87 | 74.87B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
622.61 | 37.83B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.53 | 31.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
111.56 | 26.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Moolec Science Presents Third Quarter Fiscal Year 2024 Business Update - ACCESS Newswire
Why Shares Of Moolec Science Are Skyrocketing Today - MSN
Evergreen (NASDAQ:EVGR) and Moolec Science (NASDAQ:MLEC) Head-To-Head Analysis - Defense World
Moolec Science (MLEC) Stock Price, News & Analysis - MarketBeat
Reviewing Moolec Science (NASDAQ:MLEC) & Brooge Energy (NASDAQ:BROG) - Defense World
Moolec Science Presents Third Quarter FY 2023 Business Update - ACCESS Newswire
Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call - ACCESS Newswire
Moolec Science (NASDAQ:MLEC) Shares Down 0.1% – What’s Next? - Defense World
Moolec Science Reports Financial Results Showing Decline - TipRanks
MLEC Stock Touches 52-Week Low at $0.75 Amid Market Challenges - Investing.com India
Moolec Science Presents 'Piggy Sooy', a Soybean Platform That Can Produce Significantly High Amounts of Pork Proteins - ACCESS Newswire
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025 - ACCESS Newswire
Moolec Science Presents Fiscal Year 2024 Annual Business Update - ACCESS Newswire
Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura - ACCESS Newswire
Moolec Becomes First Molecular Farming Company to Achieve USDA Approval for Plant-Grown Animal Proteins - ACCESS Newswire
Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call - ACCESS Newswire
Moolec Science to Host Third Quarter Fiscal Year 2024 Business U - GuruFocus.com
Moolec Science SA approves relocation to Cayman Islands - Investing.com India
Moolec Science SA approves relocation to Cayman Islands By Investing.com - Investing.com Australia
Moolec Science (NASDAQ:MLEC) versus Target Global Acquisition I (NASDAQ:TGAA) Critical Contrast - Defense World
Moolec Science (NASDAQ:MLEC) Is Making Moderate Use Of Debt - Simply Wall St
Moolec Science Announces AGM and EGM with Key Resolutions - TipRanks
Moolec Science (NASDAQ:MLEC) Stock Price Down 1.3% – What’s Next? - Defense World
Contrasting Moolec Science (MLEC) and Its Rivals - Defense World
Head-To-Head Contrast: Moolec Science (MLEC) & Its Rivals - Defense World
Comparing Moolec Science (MLEC) and Its Peers - Defense World
Moolec Science (MLEC) and Its Peers Critical Comparison - Defense World
Head-To-Head Contrast: Moolec Science (MLEC) vs. Its Competitors - Defense World
Moolec Science (MLEC) vs. The Competition Head-To-Head Contrast - Defense World
Moolec Becomes First Molecular Farming Company to Achieve USDA A - GuruFocus.com
Analyzing Moolec Science (MLEC) & Its Rivals - Defense World
Moolec Science (MLEC) versus Its Competitors Critical Review - Defense World
Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call - GuruFocus.com
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Moolec Confirms US Harvest and Promising Yields for Plant-Grown - GuruFocus.com
Analyzing Moolec Science (MLEC) & The Competition - Defense World
Critical Review: Moolec Science (MLEC) & Its Competitors - Defense World
Moolec Has Received USDA Approval for the First Genetically Modified Pea in History - ACN Newswire
Contrasting Moolec Science (MLEC) and Its Competitors - Defense World
Biotech Wants Vegetarians to Eat Its Peas Spliced With Beef DNA - Bloomberg
Financial Analysis: Moolec Science (NASDAQ:MLEC) versus Thunder Bridge Capital Partners IV (NASDAQ:THCP) - Defense World
Moolec Science gains USDA nod for iron-rich GE peas By Investing.com - Investing.com South Africa
Moolec Science gains USDA nod for iron-rich GE peas - Investing.com India
Moolec Science (MLEC) and Its Competitors Head to Head Review - Defense World
Head-To-Head Survey: Moolec Science (MLEC) vs. Its Rivals - Defense World
Moolec Science SA (MLEC) Q4 2024 Earnings Call Transcript Highlights: Revenue Surge and ... By GuruFocus - Investing.com Canada
Moolec Science Full Year 2024 Earnings: US$0.19 loss per share (vs US$1.50 loss in FY 2023) - Yahoo Finance
Moolec Science Presents First Quarter Fiscal Year 2024 Business Update, Business Wires News - AsiaOne
Moolec Science price target lowered to $3 from $6 at Maxim - TipRanks
Maxim Group cuts Moolec Science stock price target, keeps Buy rating - Investing.com
Moolec Science (NASDAQ:MLEC) Issues Earnings Results, Misses Expectations By $0.01 EPS - Defense World
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.13%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):